{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:21:45Z","timestamp":1787808105698,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00266-025-05394-7","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:11:08Z","timestamp":1762895468000},"page":"1340-1353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Efficacy and Safety of Platelet Rich Plasma (PRP) versus Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"50","author":[{"given":"Muhammad","family":"Umar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza Mohammad Ali","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"8","key":"5394_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","volume":"83","author":"S Devjani","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701\u201315. https:\/\/doi.org\/10.1007\/s40265-023-01880-x.","journal-title":"Drugs"},{"key":"5394_CR2","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/CCID.S385861","volume":"16","author":"M Kaiser","year":"2023","unstructured":"Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Treatment of androgenetic alopecia: current guidance and unmet needs. Clin Cosmet Investig Dermatol. 2023;16:1387\u2013406. https:\/\/doi.org\/10.2147\/CCID.S385861.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"5394_CR3","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","volume":"20","author":"MS Nestor","year":"2021","unstructured":"Nestor MS, Ablon G, Grade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759\u201381. https:\/\/doi.org\/10.1111\/jocd.14537.","journal-title":"J Cosmet Dermatol"},{"key":"5394_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0379.2011.07802.x","author":"A Blumeyer","year":"2011","unstructured":"Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011. https:\/\/doi.org\/10.1111\/j.1610-0379.2011.07802.x.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"5394_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","volume":"33","author":"A Gupta","year":"2022","unstructured":"Gupta A, Talukder M, Venkataraman M, et al. Minoxidil: a comprehensive review. J Dermatolog Treat. 2022;33(4):1896\u2013906. https:\/\/doi.org\/10.1080\/09546634.2021.1945527.","journal-title":"J Dermatolog Treat"},{"key":"5394_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.843127","volume":"9","author":"R Abdin","year":"2022","unstructured":"Abdin R, Zhang Y, Jimenez JJ. Treatment of androgenetic alopecia using PRP to target dysregulated mechanisms and pathways. Front Med (Lausanne). 2022;9:843127. https:\/\/doi.org\/10.3389\/fmed.2022.843127.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"5394_CR7","first-page":"1","volume":"24","author":"J Emer","year":"2019","unstructured":"Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019;24(5):1\u20136.","journal-title":"Skin Therapy Lett."},{"issue":"4","key":"5394_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jocd.12167","volume":"14","author":"MS Leo","year":"2015","unstructured":"Leo MS, Kumar AS, Kirit R, et al. Systematic review of the use of platelet-rich plasma in aesthetic dermatology. J Cosmet Dermatol. 2015;14(4):315\u201323. https:\/\/doi.org\/10.1111\/jocd.12167.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"5394_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/ijt.ijt_90_22","volume":"15","author":"O Olisova","year":"2023","unstructured":"Olisova O, Potapova M, Suvorov A, Koriakin D, Lepekhova A. Meta-analysis on the efficacy of platelet-rich plasma in patients with androgenetic alopecia. Int J Trichology. 2023;15(4):117\u201326. https:\/\/doi.org\/10.4103\/ijt.ijt_90_22.","journal-title":"Int J Trichology"},{"issue":"4","key":"5394_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","volume":"10","author":"RE Marx","year":"2001","unstructured":"Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225\u20138. https:\/\/doi.org\/10.1097\/00008505-200110000-00002.","journal-title":"Implant Dent"},{"issue":"1","key":"5394_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","volume":"5","author":"J Stevens","year":"2019","unstructured":"Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2019;5(1):46\u201351. https:\/\/doi.org\/10.1016\/j.ijwd.2018.08.004.","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"5394_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/PRS.0b013e31817d618d","volume":"122","author":"M Kurita","year":"2008","unstructured":"Kurita M, Aiba-Kojima E, Shigeura T, et al. Differential effects of three preparations of human serum on expansion of various types of human cells. Plast Reconstr Surg. 2008;122(2):438\u201348. https:\/\/doi.org\/10.1097\/PRS.0b013e31817d618d.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"5394_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/DSS.0000000000001965","volume":"46","author":"MJ Hesseler","year":"2020","unstructured":"Hesseler MJ, Shyam N. Platelet-rich plasma and its utilities in alopecia: a systematic review. Dermatol Surg. 2020;46(1):93\u2013102. https:\/\/doi.org\/10.1097\/DSS.0000000000001965.","journal-title":"Dermatol Surg"},{"issue":"5","key":"5394_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/jocd.12679","volume":"17","author":"ME Kramer","year":"2018","unstructured":"Kramer ME, Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia. J Cosmet Dermatol. 2018;17(5):666\u201371. https:\/\/doi.org\/10.1111\/jocd.12679.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"5394_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000477671","volume":"4","author":"J Cervantes","year":"2018","unstructured":"Cervantes J, Perper M, Wong LL, et al. Effectiveness of platelet-rich plasma for androgenetic alopecia: a review of the literature. Skin Appendage Disord. 2018;4(1):1\u201311. https:\/\/doi.org\/10.1159\/000477671.","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"5394_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2450\/2021.0216-21","volume":"21","author":"M Cruciani","year":"2023","unstructured":"Cruciani M, Masiello F, Pati I, Marano G, Pupella S, De Angelis V. Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis. Blood Transfus. 2023;21(1):24\u201336. https:\/\/doi.org\/10.2450\/2021.0216-21.","journal-title":"Blood Transfus"},{"issue":"7","key":"5394_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13315","volume":"29","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang Y, Long B, Zhang Y, Zhang C, Zhang S. Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia. Skin Res Technol. 2023;29(7):e13315. https:\/\/doi.org\/10.1111\/srt.13315.","journal-title":"Skin Res Technol"},{"key":"5394_CR18","unstructured":"Atlas Health Medical Group. Combining minoxidil and PRP injections to supercharge hair growth. Atlas Health Medical Group. 2021. https:\/\/atlashealthmedicalgroup.com\/combining-minoxidil-and-prp-injections-to-supercharge-hair-growth\/. Accessed 26 Oct 2024."},{"issue":"1","key":"5394_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jocd.14983","volume":"22","author":"EL Aukerman","year":"2023","unstructured":"Aukerman EL, Jafferany M. The psychological consequences of androgenetic alopecia: a systematic review. J Cosmet Dermatol. 2023;22(1):89\u201395. https:\/\/doi.org\/10.1111\/jocd.14983.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"5394_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bodyim.2011.06.006","volume":"8","author":"D Kranz","year":"2011","unstructured":"Kranz D. Young men\u2019s coping with androgenetic alopecia: acceptance counts when hair gets thinner. Body Image. 2011;8(4):343\u20138.","journal-title":"Body Image"},{"issue":"6","key":"5394_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/dss.0000000000002168","volume":"46","author":"AJ Bruce","year":"2020","unstructured":"Bruce AJ, Pincelli TP, Heckman MG, et al. A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women. Dermatol Surg. 2020;46(6):826\u201332. https:\/\/doi.org\/10.1097\/dss.0000000000002168.","journal-title":"Dermatol Surg"},{"key":"5394_CR22","unstructured":"Sultana BB, Paul HK. Efficacy and safety of platelet-rich plasma therapy in male androgenetic alopecia. J Pak Assoc Dermatol. 2020;30(3):375\u201381. https:\/\/www.jpad.com.pk\/index.php\/jpad\/article\/view\/1443."},{"issue":"18","key":"5394_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186516","volume":"21","author":"EE Pakhomova","year":"2020","unstructured":"Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia. Int J Mol Sci. 2020;21(18):6516. https:\/\/doi.org\/10.3390\/ijms21186516.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5394_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.ewx.0000472824.29209.a8","volume":"13","author":"CI Farid","year":"2016","unstructured":"Farid CI, Abdelmaksoud RA. Platelet-rich plasma microneedling versus 5% topical minoxidil in the treatment of patterned hair loss. J Egypt Womens Dermatol Soc. 2016;13(1):29\u201336. https:\/\/doi.org\/10.1097\/01.ewx.0000472824.29209.a8.","journal-title":"J Egypt Womens Dermatol Soc"},{"key":"5394_CR25","doi-asserted-by":"publisher","unstructured":"Afzal G, Ahmed N, Zahoor F, Malik T, Farooq O. Efficacy of platelet-rich plasma versus 5% topical minoxidil for the treatment of androgenetic alopecia. J Coll Physicians Surg Pak. 2024;34(1):11-15. https:\/\/doi.org\/10.29271\/jcpsp.2024.01.11.","DOI":"10.29271\/jcpsp.2024.01.11"},{"issue":"2","key":"5394_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/ijt.ijt_64_18","volume":"11","author":"K Verma","year":"2019","unstructured":"Verma K, Tegta G, Verma G, et al. A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia. Int J Trichology. 2019;11(2):68. https:\/\/doi.org\/10.4103\/ijt.ijt_64_18.","journal-title":"Int J Trichology"},{"key":"5394_CR27","doi-asserted-by":"publisher","unstructured":"Shah R, Asim M, Ouellette S, Sharif S, Shah A, Rao B. A randomized control trial comparing the efficacy of Platelet-Rich Plasma and 5% topical minoxidil for the treatment of androgenetic alopecia. J Drugs Dermatol. 2023;22(9):905-909. https:\/\/doi.org\/10.36849\/jdd.7031.","DOI":"10.36849\/jdd.7031"},{"key":"5394_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2182618","author":"M Balasundaram","year":"2023","unstructured":"Balasundaram M, Kumari R, Ramassamy S. Efficacy of autologous platelet-rich plasma therapy versus topical minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial. J Dermatolog Treat. 2023. https:\/\/doi.org\/10.1080\/09546634.2023.2182618.","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"5394_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4103\/ijdvl.ijdvl_589_18","volume":"86","author":"SK Singh","year":"2020","unstructured":"Singh SK, Kumar V, Rai T. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial. Indian J Dermatol Venereol Leprol. 2020;86(2):150. https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_589_18.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"21","key":"5394_CR30","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1007\/s00266-024-04054-6","volume":"48","author":"C Xiao","year":"2024","unstructured":"Xiao C, Zhang GH, Li HQ, Yang PP, Zhang HB, Mu YX. Meta-analysis of efficacy of platelet-rich plasma combined with minoxidil for androgenetic alopecia. Aesthet Plast Surg. 2024;48(21):4554\u201366. https:\/\/doi.org\/10.1007\/s00266-024-04054-6.","journal-title":"Aesthet Plast Surg"},{"issue":"5","key":"5394_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00266-023-03603-9","volume":"48","author":"M Li","year":"2024","unstructured":"Li M, Qu K, Lei Q, Chen M, Bian D. Effectiveness of platelet-rich plasma in the treatment of androgenic alopecia: a meta-analysis. Aesthet Plast Surg. 2024;48(5):977\u201384. https:\/\/doi.org\/10.1007\/s00266-023-03603-9.","journal-title":"Aesthet Plast Surg"},{"issue":"10","key":"5394_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/DSS.0000000000001894","volume":"45","author":"AK Gupta","year":"2019","unstructured":"Gupta AK, Cole J, Deutsch DP, Everts PA, Niedbalski RP, Panchaprateep R, et al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol Surg. 2019;45(10):1262\u201373. https:\/\/doi.org\/10.1097\/DSS.0000000000001894.","journal-title":"Dermatol Surg"},{"issue":"5","key":"5394_CR33","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/j.jaad.2022.01.035","volume":"86","author":"DM Elston","year":"2022","unstructured":"Elston DM. Letter from the editor: Meta-analysis, study heterogeneity, and clinical significance. J Am Acad Dermatol. 2022;86(5):e245\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2022.01.035.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5394_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030342","volume":"12","author":"SR Georgescu","year":"2022","unstructured":"Georgescu SR, Amuzescu A, Mitran CI, Mitran MI, Matei C, Constantin C, et al. Effectiveness of platelet-rich plasma therapy in androgenic alopecia: a meta-analysis. J Pers Med. 2022;12(3):342. https:\/\/doi.org\/10.3390\/jpm12030342.","journal-title":"J Pers Med"},{"issue":"2","key":"5394_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024537","volume":"9","author":"R Phillips","year":"2019","unstructured":"Phillips R, Hazell L, Sauzet O, Cornelius V. Analysis and reporting of adverse events in randomised controlled trials: a review. BMJ Open. 2019;9(2):e024537. https:\/\/doi.org\/10.1136\/bmjopen-2018-024537.","journal-title":"BMJ Open"},{"issue":"5","key":"5394_CR36","first-page":"5","volume":"19","author":"AK Gupta","year":"2014","unstructured":"Gupta AK, Foley KA. 5% minoxidil: treatment for female pattern hair loss. Skin Ther Lett. 2014;19(5):5\u20137.","journal-title":"Skin Ther Lett"},{"issue":"1","key":"5394_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jocd.12357","volume":"17","author":"AA Tawfik","year":"2018","unstructured":"Tawfik AA, Osman MAR. The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. J Cosmet Dermatol. 2018;17(1):47\u201353.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"5394_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0974-2077.150743","volume":"7","author":"MA Gkini","year":"2014","unstructured":"Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through a one-year period. J Cutan Aesthet Surg. 2014;7(4):213\u20139. https:\/\/doi.org\/10.4103\/0974-2077.150743.","journal-title":"J Cutan Aesthet Surg"},{"issue":"2","key":"5394_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0974-2077.138352","volume":"7","author":"SS Khatu","year":"2014","unstructured":"Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg. 2014;7(2):107\u201310.","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"5394_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00238-013-0816-5","volume":"36","author":"EE Betsi","year":"2013","unstructured":"Betsi EE, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. Eur J Plast Surg. 2013;36(6):407\u201312.","journal-title":"Eur J Plast Surg"},{"issue":"1","key":"5394_CR41","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.15144","volume":"33","author":"MB S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard MB, Ghazanfar MN, Thomsen SF. Patient expectations and determinants of patient satisfaction in a dermatology outpatient clinic. J Eur Acad Dermatol Venereol. 2019;33(1):e32\u20133. https:\/\/doi.org\/10.1111\/jdv.15144.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"5394_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5021\/ad.2012.24.3.311","volume":"24","author":"SH Han","year":"2012","unstructured":"Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol. 2012;24(3):311\u20138. https:\/\/doi.org\/10.5021\/ad.2012.24.3.311.","journal-title":"Ann Dermatol"},{"issue":"8","key":"5394_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308986","volume":"19","author":"J Yao","year":"2024","unstructured":"Yao J, Zhu L, Pan M, Shen L, Tang Y, Fan L. The additive value of platelet-rich plasma to topical minoxidil in the treatment of androgenetic alopecia: a systematic review and meta-analysis. PLoS ONE. 2024;19(8):e0308986. https:\/\/doi.org\/10.1371\/journal.pone.0308986.","journal-title":"PLoS ONE"},{"key":"5394_CR44","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13555-024-01133-z","volume":"14","author":"S Va\u00f1\u00f3-Galv\u00e1n","year":"2024","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Egeberg A, Piraccini BM, et al. Characteristics and management of patients with alopecia areata and selected comorbid conditions: results from a survey in five European countries. Dermatol Ther (Heidelb). 2024;14:1027\u201337. https:\/\/doi.org\/10.1007\/s13555-024-01133-z.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"5394_CR45","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1111\/jocd.16473","volume":"23","author":"J Jimenez-Cauhe","year":"2024","unstructured":"Jimenez-Cauhe J, Va\u00f1o-Galvan S, Mehta N, et al. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia. J Cosmet Dermatol. 2024;23:3767\u201373. https:\/\/doi.org\/10.1111\/jocd.16473.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"5394_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/skinhd\/vzaf009","volume":"5","author":"F Fazal","year":"2025","unstructured":"Fazal F, Malik BH, Mumtaz Malik H, et al. Can oral minoxidil be the game changer in androgenetic alopecia? A comprehensive review and meta-analysis comparing topical and oral minoxidil for treating androgenetic alopecia. Skin Health Dis. 2025;5(2):95\u2013101. https:\/\/doi.org\/10.1093\/skinhd\/vzaf009.","journal-title":"Skin Health Dis"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-025-05394-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:05:31Z","timestamp":1773677131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-025-05394-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5394"],"URL":"https:\/\/doi.org\/10.1007\/s00266-025-05394-7","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All the authors gave their consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"(CRD42024570523)","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prospero"}}]}}